Neuronetics (STIM) Cash from Operations Growth (5y) (2022 - 2026)
Neuronetics (STIM) Cash from Operations Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Neuronetics | 120.39 Mn | 114.38 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.55% |
| Dec 31, 2025 | 20.38% |
| Sep 30, 2025 | 25.80% |
| Jun 30, 2025 | 18.04% |
| Mar 31, 2025 | -4.48% |
| Dec 31, 2024 | -6.07% |
| Sep 30, 2024 | 6.70% |
| Jun 30, 2024 | 6.21% |
| Mar 31, 2024 | -4.66% |
| Dec 31, 2023 | 24.05% |
| Sep 30, 2023 | -15.53% |
| Jun 30, 2023 | -11.61% |
| Mar 31, 2023 | -12.89% |
| Dec 31, 2022 | -68.46% |
| Sep 30, 2022 | -27.50% |